ACM
RGNX icon

ADAR1 Capital Management’s Regenxbio RGNX Stock Holding History

ADAR1 Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-44,416
Closed -$372K – 332
2026
Q1 		$372K Sell
44,416
-100,432
-69% -$1.06M 0.02% 224
2025
Q4 		$2.09M Sell
144,848
-60,561
-29% -$755K 0.15% 97
2025
Q3 		$1.98M Sell
205,409
-2,409
-1% -$21.3K 0.19% 79
2025
Q2 		$1.71M Sell
207,818
-142,534
-41% -$1.19M 0.26% 61
2025
Q1 		$2.51M Buy
350,352
+180,223
+106% +$1.34M 0.47% 53
2024
Q4 		$1.32M Sell
170,129
-398,879
-70% -$3.75M 0.26% 66
2024
Q3 		$5.97M Buy
569,008
+566,308
+20,974% +$6.9M 0.97% 24
2024
Q2 		$31.6K Buy
2,700
+200
+8% +$3.11K 0.01% 204
2024
Q1 		$52.7K Buy
+2,500
New +$44.5K 0.01% 176

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

ADAR1 Capital Management's RGNX Position: Q2 2026 in Review

ADAR1 Capital Management sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 44,416 shares — an estimated $372K sold.

ADAR1 Capital Management first reported a position in RGNX in Q1 2024 and held it in 9 quarters. The position peaked at $5.97M in Q3 2024. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • ADAR1 Capital Management reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • ADAR1 Capital Management sold 44,416 Regenxbio shares in Q2 2026, an estimated $372K.
  • ADAR1 Capital Management first reported a position in Regenxbio in Q1 2024 and held it in 9 quarters.
  • ADAR1 Capital Management's Regenxbio position peaked at $5.97M in Q3 2024.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.